Diagnosing the mild cognitive impairment stage of Alzheimer's disease

Masahiro Maruyama, Toshifumi Matsui, Haruko Tanji, Mari Ootsuki, Miyako Nemoto, Naoki Tomita, Nobuyuki Okamura, Sachio Matsushita, Susumu Higuchi, Manabu Kodama, Hiroyuki Arai, Hidetada Sasaki

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

Recently, it has become important to diagnose Alzheimer's Disease (AD) at an early stage due to the development of AD therapy. Also, there is increasing recognition of a class of elderly people with complaints of memory loss but who nevertheless do not meet the criteria for dementia. "Mild cognitive impairment" (MCI) is the term used for this disorder, and amnestic MCI is highly converted to AD. In this study we evaluated the accuracy of diagnosis of amnestic MCI by cerebrospinal fluid total-tau protein (CSF/total-tau), cerebrospinal fluid amyloid beta 1-42 protein (CSF/A beta 1-42), and cerebral blood flow in the posterior cingulate cortex using SPECT. CSF/total-tau was the most appropriate to discriminate between normal cognitive individuals and those with amnestic MCI. We also evaluated the CSF/total-tau and MRI images between patients with stable MCI and those with progressive MCI, including those who converted to AD in the following two years. The stable type was characterized by normal CSF/total-tau levels and relatively high grade periventricular white matter lesions (PWML). Conversely, the progressive type was characterized by high CSF-tau levels and relatively low grade PWML. We speculate that stable MCI is due to ischemic change with in the white matter lesion, while progressive MCI may represent a previous stage of AD.

Original languageEnglish
Pages (from-to)269-280
Number of pages12
JournalSeishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
Volume106
Issue number3
Publication statusPublished - 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Diagnosing the mild cognitive impairment stage of Alzheimer's disease'. Together they form a unique fingerprint.

Cite this